The increased levels of HMGB1 in serum/plasma were observed in numerous inflammation-driven human diseases, such as autoimmune disorders (rheumatoid arthritis, systemic lupus erythematosus (SLE), and vessel vasculitis [12,15,16,17]) and cancer. The gene discussed is HMGB1; the disease is cancer.